2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.
Carlos TaxoneraIñigo SagastagoitiaCristina AlbaNorberto MañasDavid OlivaresEnrique ReyPublished in: Alimentary pharmacology & therapeutics (2020)
IBD patients do not have an increased risk of COVID-19 and associated mortality compared with the general population. In many IBD patients, diarrhoea was a presenting symptom, and sometimes, was the only symptom at onset of COVID-19.